Position in EXEL
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$584,762
-$20,223 QoQ
Shares Held
13,634
-1.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEPHENS INC /AR/ holds $6,968,085 across 12 Biotechnology names. EXEL ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
26,761 | $2,009,483 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,951 | $1,317,739 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
887 | $685,331 | |
| 4 | TECH |
BIO-TECHNE Corp
|
12,422 | $649,173 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
13,634 | $584,762 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,425 | $471,489 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
1,625 | $324,431 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,557 | $294,518 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $584,762 | 13,634 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $604,985 | 13,803 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $369,387 | 8,944 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $395,529 | 8,973 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $2,709,854 | 73,398 | Shares | Defined | 2025-05-01 | |
| 2024-12-31 | $297,668 | 8,939 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $251,429 | 9,689 | Shares | Defined | 2024-10-28 | |
| 2024-03-31 | $205,596 | 8,664 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $208,521 | 8,692 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $198,113 | 9,067 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $174,397 | 9,126 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $181,599 | 9,356 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $145,097 | 9,046 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $141,841 | 9,046 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $190,627 | 9,156 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $216,589 | 9,554 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $178,266 | 9,752 | Shares | Defined | 2022-03-07 | |
| 2021-09-30 | $163,792 | 7,748 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $95,818 | 5,259 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $85,412 | 3,781 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,683 | 333 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $17,090 | 699 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,911 | 586 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $3,547 | 206 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||